EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Rk3 Treats Corneal Injury Through the HMGB1/TLR4/NF-κB Pathway

Linlin Qu iD, Yingcong Huang, Yuqing Wu, Lei He, Yannan Liu, Zhiqi Chen, Xiaoxuan Ma, Daidi Fan

Journal of Agricultural and Food Chemistry · 06.11.2024 · 72 (44) · 24387-24399

DOI: 10.1021/acs.jafc.4c04250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 22.10.2024. Verfasst von Linlin Qu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, North…. Hauptthemen laut MEDLINE: Ginsenosides, NF-kappa B, Corneal Injuries, Cornea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesNF-kappa BCorneal InjuriesCorneaToll-Like Receptor 4HMGB1 ProteinSignal TransductionAnimalsMiceHumansMaleMice, Inbred C57BL

Stichwörter der Autor:innen

HMGB1barriercorneal injuryginsenoside Rk3inflammation

Substanzen

GinsenosidesNF-kappa BToll-Like Receptor 4HMGB1 Proteinginsenoside Rk3

Autor:innen und Institutionen

  • Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi'an 710127, China.
  • Biotech. & Biomed. Research Institute, Northwest University, Xi'an 710127, China.
  • Xi'an Giant Biotechnology Co., Ltd., Xi'an 710076, China.
  • Shaanxi Giant Biotechnology Co., Ltd., Xi'an 710065, China.

ORCID-Profile: Linlin Qu

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Natural Science Basic Research Program of Shaanxi Province
  • Xi'an Science and Technology Association
  • National Natural Science Foundation of China
  • Xi'an Postdoctoral Innovation Base Funding Project

Zitieren

APA

Qu, L., Huang, Y., Wu, Y., He, L., Liu, Y., Chen, Z., Ma, X., & Fan, D. (2024). Ginsenoside Rk3 Treats Corneal Injury Through the HMGB1/TLR4/NF-κB Pathway. Journal of Agricultural and Food Chemistry, 72(44), 24387-24399. https://doi.org/10.1021/acs.jafc.4c04250

Vancouver

Qu L, Huang Y, Wu Y, He L, Liu Y, Chen Z, et al. Ginsenoside Rk3 Treats Corneal Injury Through the HMGB1/TLR4/NF-κB Pathway. Journal of Agricultural and Food Chemistry. 2024;72(44):24387-24399. doi:10.1021/acs.jafc.4c04250

BibTeX
@article{Qu2024,
  author = {Qu, Linlin and Huang, Yingcong and Wu, Yuqing and He, Lei and Liu, Yannan and Chen, Zhiqi and Ma, Xiaoxuan and Fan, Daidi},
  title = {Ginsenoside Rk3 Treats Corneal Injury Through the HMGB1/TLR4/NF-κB Pathway},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2024},
  volume = {72},
  number = {44},
  pages = {24387--24399},
  doi = {10.1021/acs.jafc.4c04250}
}
Kostenlos starten →